Similar articles

• Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.

  Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KM, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto AM Jr, Ridker PM, Kastelein JJ. Boekholdt SM, et al. JAMA. 2012 Mar 28;307(12):1302-9. doi: 10.1001/jama.2012.366. JAMA. 2012. PMID: 22453571
• Lipid parameters and cardiovascular events in patients taking statins.

  Brook RD, Rubenfire M. Brook RD, et al. JAMA. 2012 Jul 11;308(2):132; author reply 132-3. doi: 10.1001/jama.2012.6616. JAMA. 2012. PMID: 22782403 No abstract available.
• Lipid parameters and cardiovascular events in patients taking statins.

  Martin SS, Jones SR. Martin SS, et al. JAMA. 2012 Jul 11;308(2):131-2; author reply 132-3. doi: 10.1001/jama.2012.6614. JAMA. 2012. PMID: 22782402 No abstract available.
• New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.

  Sahebkar A, Watts GF. Sahebkar A, et al. Clin Ther. 2013 Aug;35(8):1082-98. doi: 10.1016/j.clinthera.2013.06.019. Epub 2013 Aug 8. Clin Ther. 2013. PMID: 23932550 Review.
• Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials.

  Robinson JG, Wang S, Jacobson TA. Robinson JG, et al. Am J Cardiol. 2012 Nov 15;110(10):1468-76. doi: 10.1016/j.amjcard.2012.07.007. Epub 2012 Aug 17. Am J Cardiol. 2012. PMID: 22906895 Review.